Physicians' Academy for Cardiovascular Education

Suboptimal medical therapy for ACS patients is associated with increased mortality

Trends in Optimal Medical Therapy Prescription and Mortality After Admission for Acute Coronary Syndrome: a 9-Year Experience in a Real-World Setting

Literature - Hoedemaker NPG, Damman P, Ottervanger JP, et al. - Eur Heart J - CV Pharmacotherapy 2018

Main results


In a single-center observational study, less than 50% of acute coronary syndrome patients were on aspirin, P2Y12 inhibitor, statin, beta-blocker, and ACEi/ARB at discharge. The prescription of these recommended therapies at discharge was associated with a reduction in 1-year mortality.


Show references

Find this article online at Eur Heart J - CV Pharmacotherapy

Share this page with your colleagues and friends: